Daily injectables (liraglutide) require daily attention
How often should I get IM injections
Notably, the effect of tirzepatide as an anti-obesity medication is being investigated in the ongoing SURMOUNT clinical trial programme, in a similar manner to the assessment of semaglutide 2.4 mg for obesity in the Semaglutide Treatment Effect in People with obesity (STEP) programme [27]
For more information on responsibilities when prescribing for an 'off-label' use please click here
To learn about more food suggestions, check out what to eat when using GLP-1 medication
GLP-1s are prescribed to adults with a BMI over 30, or adults with a BMI over 27 who also have obesity-related conditions, such as prediabetes, diabetes, high blood pressure, high cholesterol, sleep apnea, and fatty liver disease